Large international study reveals spectrum of COVID-19 brain complications

Large international study reveals spectrum of COVID-19 brain complications
49-year-old female with past medical history of mitral valve disease and tricuspid valve regurgitation who developed headache followed by cough and fever presented to the ER with right upper eyelid ptosis (drooping). Credit: Radiological Society of North America and Scott H. Faro, M.D.

The largest multi-institutional international study to date on brain complications of COVID-19 has found that approximately one in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system. These can include stroke, hemorrhage, and other potentially fatal complications. The study is being presented tomorrow at the annual meeting of the Radiological Society of North America (RSNA).

"Much has been written about the overall pulmonary problems related to COVID-19, but we do not often talk about the other organs that can be affected," said study lead author Scott H. Faro, M.D., FASFNR, professor of radiology and neurology and director of the Division of Neuroradiology/Head & Neck Imaging at Thomas Jefferson University in Philadelphia. "Our study shows that central nervous system complications represent a significant cause of morbidity and mortality in this devastating pandemic."

Dr. Faro initiated the study after discovering that existing literature on central nervous system complications in hospitalized COVID-19 infected patients was based on a relatively small number of cases.

To derive a more complete picture, he and his colleagues analyzed nearly 40,000 cases of hospitalized COVID-19 positive patients from seven U.S. and four western European university hospitals. The patients had been admitted between September 2019 and June 2020. Their average age was 66 years old, and there were twice as many men as women.

Large international study reveals spectrum of COVID-19 brain complications
Hemorrhage seen in 56-year-old female with COVID-19 infection and no other significant past medical history. Credit: RSNA and Scott H. Faro, M.D.

The most common cause of admission was confusion and altered mental status, followed by fever. Many of the patients had comorbidities like hypertension, cardiac disease and diabetes.

There were 442 acute neuroimaging findings that were most likely associated with the viral infection. The overall incidence of central nervous system complications in this large patient group was 1.2%.

"Of all the inpatients who had imaging such as MRI or a CT scan of brain, the exam was positive approximately 10% of the time," Dr. Faro said. "The incidence of 1.2% means that a little more than one in 100 patients admitted to the hospital with COVID-19 are going to have a brain problem of some sort."

The most common was , with an incidence of 6.2%, followed by (3.72%) and encephalitis (0.47%), an inflammation of the brain.

Large international study reveals spectrum of COVID-19 brain complications
65-year-old male smoker, presented with acute hypoxic respiratory failure secondary to COVID-19 pneumonia, requiring intubation. Hospitalization was complicated by seizures relating to cerebral edema and hemorrhagic posterior reversible encephalopathy syndrome. Credit: RSNA and Scott H. Faro, M.D.

The researchers also discovered a small percentage of unusual findings, such as acute disseminating encephalomyelitis, an and , and posterior reversible encephalopathy syndrome, a syndrome that mimics many of the symptoms of a stroke.

"It is important to know an accurate incidence of all the major central nervous system complications," Dr. Faro said. "There should probably be a low threshold to order imaging for patients with COVID-19."


Explore further

Study uncovers clues to COVID-19 in the brain

Citation: Large international study reveals spectrum of COVID-19 brain complications (2021, November 29) retrieved 25 May 2022 from https://medicalxpress.com/news/2021-11-large-international-reveals-spectrum-covid-.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
8 shares

Feedback to editors